Free Trial
NASDAQ:BFRG

Bullfrog AI Q4 2025 Earnings Results & Report

Bullfrog AI logo
$0.54 -0.01 (-2.08%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$0.53 -0.01 (-1.39%)
As of 11/13/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bullfrog AI reported Q4 2025 earnings on March 19, 2026. The company reported EPS of -$0.12.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
After Market Closes
Conference Call
8:00 AM ET

Bullfrog AI EPS Results

Actual EPS
-$0.12
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bullfrog AI Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Earnings Documents

Bullfrog AI Q4 2025 Earnings FAQ

Bullfrog AI (NASDAQ:BFRG) reported earnings of -$0.12 per share for Q4 2025. The report was announced on Thursday, March 19, 2026.

Bullfrog AI Earnings Headlines

Bullfrog AI (BFRG) Expected to Release Quarterly Earnings on Friday
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
See More Bullfrog AI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bullfrog AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bullfrog AI and other key companies, straight to your email.

About Bullfrog AI

Bullfrog AI (NASDAQ:BFRG) Holdings, Inc. is a biotechnology-focused artificial intelligence company that develops machine-learning tools for the healthcare and life sciences industries. The company’s work is centered on using artificial intelligence to analyze complex biomedical data and support more efficient approaches to drug development and precision medicine.

Its primary technology platform, bfLEAP, is designed to process and interpret large datasets, including genomic and clinical information. BullFrog AI offers data analysis and related services intended to help pharmaceutical companies, biotechnology firms, researchers and other healthcare organizations identify patterns, potential biomarkers, patient subgroups and other insights that may inform therapeutic development.

The company has positioned its business around applying artificial intelligence to areas such as oncology, neurological disorders and other complex diseases. BullFrog AI is headquartered in the United States and primarily operates in the healthcare and biotechnology markets, working with organizations that need advanced analytics for biomedical research and drug-development programs.

View Bullfrog AI Profile